Clinical Trial Update: Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase I/II clinical trial evaluating hydroxychloroquine in combination with itraconazole for biochemically recurrent prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Itraconazole (Itraconazole)

Snippet

Sponsor: St Vincent's Hospital, Sydney | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED